• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fuji and Olicon strike PACS alliance

Article

Fuji Medical Systems USA and Olicon Imaging Systems this month signed a nonexclusive licensing and product distribution agreement. The deal enables Fuji, which has specialized in the development of computed radiography systems, to sell turnkey PACS

Fuji Medical Systems USA and Olicon Imaging Systems this month signed a nonexclusive licensing and product distribution agreement. The deal enables Fuji, which has specialized in the development of computed radiography systems, to sell turnkey PACS solutions to hospitals.

Under the terms of the agreement, Fuji will distribute Olicon's PACS products when customers desire a single-vendor solution for PACS and CR, according to Clay Larsen, managing director of marketing for Stamford, CT-based Fuji. Fuji can now directly offer its CR customers PACS products, whereas in the past, it had to refer them to another vendor, Larsen said.

San Clemente, CA-based Olicon, on the other hand, will license Fuji's CR image processing algorithms for use on Olicon's workstations, making them more suited for primary CR reading by radiologists, according to Dick Paulsen, Olicon's CEO. Olicon also believes the agreement will give the company an advantage in marketing its products to Fuji CR customers who are interested in upgrading to PACS.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.